NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical studies when compared to traditional osteoconductive synthetic scaffolds.
NuVasive announced the launch of AttraX Putty and four other technologies earlier this quarter at the annual American Association of Neurological Surgeons meeting.
NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical...
NuVasive announced the U.S. launch of AttraX® Putty, the newest product in its biologics portfolio.
AttraX Putty is a next generation, synthetic bone graft product intended for use as an autograft extender in the posterior lateral spine. The biotextured™ surface features of AttraX Putty help to regenerate bone, demonstrated in pre-clinical studies when compared to traditional osteoconductive synthetic scaffolds.
NuVasive announced the launch of AttraX Putty and four other technologies earlier this quarter at the annual American Association of Neurological Surgeons meeting.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
